Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

Total article views   Abstract views HTML views PDF downloads Totals
11,896 Dovepress* 11,896 0+ 2,986 11,896
Totals 11,896 0 2,986 11,896
*Since 12 April 2010
+Since July 2016

View citations on Google Scholar